Cyclo Therapeutics, Inc. (CYTH) Costs and Expenses USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Cyclo Therapeutics, Inc. quarterly/annual Costs and Expenses history and growth rate from 2010 to 2024.
  • Cyclo Therapeutics, Inc. Costs and Expenses for the quarter ending March 31, 2024 was $5.31 M, a 3.15% increase year-over-year.
  • Cyclo Therapeutics, Inc. Costs and Expenses for the twelve months ending March 31, 2024 was $21.2 M, a 12.3% increase year-over-year.
  • Cyclo Therapeutics, Inc. annual Costs and Expenses for 2023 was $21 M, a 24.8% increase from 2022.
  • Cyclo Therapeutics, Inc. annual Costs and Expenses for 2022 was $16.9 M, a 6.19% increase from 2021.
  • Cyclo Therapeutics, Inc. annual Costs and Expenses for 2021 was $15.9 M, a 60.9% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $21.2 M $5.31 M +$162 K +3.15% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $21 M $5.88 M +$849 K +16.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-18
Q3 2023 $20.2 M $5.26 M +$562 K +12% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $19.6 M $4.75 M +$752 K +18.8% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $18.9 M $5.15 M +$2.02 M +64.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $16.9 M $5.03 M +$1.65 M +48.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-18
Q3 2022 $15.2 M $4.7 M +$438 K +10.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $14.8 M $4 M +$159 K +4.14% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $14.6 M $3.13 M -$1.27 M -28.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $15.9 M $3.38 M +$551 K +19.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-17
Q3 2021 $15.3 M $4.26 M +$2.6 M +157% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $12.7 M $3.84 M +$1.43 M +59.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $11.3 M $4.4 M +$1.43 M +48.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $9.86 M $2.83 M -$38.2 K -1.33% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-11
Q3 2020 $9.9 M $1.66 M -$256 K -13.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $10.2 M $2.41 M +$768 K +46.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $9.39 M $2.97 M +$839 K +39.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $8.55 M $2.87 M +$1.26 M +78.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-12
Q3 2019 $7.29 M $1.91 M +$900 K +88.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $6.39 M $1.64 M -$776 -0.05% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 $6.39 M $2.13 M +$1.12 M +110% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 $5.28 M $1.61 M +$53.9 K +3.47% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 $5.22 M $1.01 M +$136 K +15.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $5.09 M $1.64 M +$290 K +21.4% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 $4.8 M $1.01 M -$283 K -21.9% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 $5.08 M $1.55 M +$231 K +17.5% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-15
Q3 2017 $4.85 M $878 K -$1.01 M -53.5% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $5.86 M $1.35 M -$97.9 K -6.74% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $5.96 M $1.3 M +$250 K +23.9% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 $5.71 M $1.32 M Oct 1, 2016 Dec 31, 2016 10-K 2018-04-16
Q3 2016 $1.89 M +$914 K +93.8% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $1.45 M +$719 K +98.1% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-11
Q1 2016 $1.05 M +$490 K +88.2% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
Q3 2015 $975 K +$390 K +66.6% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 $733 K +$346 K +89.6% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-12
Q1 2015 $556 K +$154 K +38.2% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q3 2014 $585 K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 $387 K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 $402 K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q3 2012 $1 M $186 K -$91.4 K -33% Jul 1, 2012 Sep 30, 2012 10-Q 2012-11-13
Q2 2012 $1.09 M $207 K -$121 K -36.9% Apr 1, 2012 Jun 30, 2012 10-Q 2012-08-14
Q1 2012 $1.21 M $366 K +$107 K +41.3% Jan 1, 2012 Mar 31, 2012 10-Q 2012-05-21
Q4 2011 $1.11 M $241 K Oct 1, 2011 Dec 31, 2011 10-K 2012-03-16
Q3 2011 $277 K +$66.8 K +31.7% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
Q2 2011 $329 K +$199 K +154% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 $259 K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-21
Q3 2010 $211 K Jul 1, 2010 Sep 30, 2010 10-Q/A 2012-02-23
Q2 2010 $129 K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.